Sign in
4/A

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-23-004608

10% owner acquired 4,466 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cambrian BioPharma Inc · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-10 Grant or award : show line 1 in the form +4,466 5,235,956 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-10 Grant or award : show line 2 in the form Stock Option (right to buy) +14,550 14,550 D
Loading xslF345X03/doc1.xml…